Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-001845
Filing Date
2013-08-05
Accepted
2013-08-02 17:54:02
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q affy06301310q.htm 10-Q 1076345
2 EX-31.1 affy033113ex3111.htm EX-31.1 10166
3 EX-31.2 affy033113ex3121.htm EX-31.2 10175
4 EX-32.1 affy033113ex3211.htm EX-32.1 9733
  Complete submission text file 0001445305-13-001845.txt   11207427

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT affy-20130630.xml EX-101.INS 1143559
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT affy-20130630.xsd EX-101.SCH 53296
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT affy-20130630_cal.xml EX-101.CAL 69222
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT affy-20130630_def.xml EX-101.DEF 380332
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT affy-20130630_lab.xml EX-101.LAB 622131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT affy-20130630_pre.xml EX-101.PRE 435441
Mailing Address 19200 STEVENS CREEK BOULEVARD SUITE 240 CUPERTINO CA 94014
Business Address 19200 STEVENS CREEK BOULEVARD SUITE 240 CUPERTINO CA 94014 650-812-8700
AFFYMAX INC (Filer) CIK: 0001158223 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33213 | Film No.: 131007585
SIC: 2834 Pharmaceutical Preparations